4
Orphan Designations
0 approved, 1 designated
1
FDA Approvals
Latest: LYSODREN (1970)
0
Active Trials
0
Rare Diseases
0
News (30d)
Quiet
ESTEVE PHARMACEUTICALS, S.A. is a company with 4 orphan drug designations across 0 rare diseases, including 1 FDA-approved therapy.
Disease-by-disease pipeline progression from orphan designation through clinical trials to FDA approval.
Source: FDA Orphan Drug Designations, ClinicalTrials.gov, Drugs@FDA
No pipeline data available yet.